Lactobacillus plantarum ZS2058 produces CLA to ameliorate DSS-induced acute colitis in mice

RSC Advances ◽  
2016 ◽  
Vol 6 (18) ◽  
pp. 14457-14464 ◽  
Author(s):  
Juntong Wang ◽  
Haiqin Chen ◽  
Bo Yang ◽  
Zhennan Gu ◽  
Hao Zhang ◽  
...  

Lactobacillus plantarumZS2058 is an efficient producer of conjugated linoleic acid (CLA)in vitro.

2012 ◽  
Vol 41 (4) ◽  
pp. 399-411
Author(s):  
Siddharth Krishnan ◽  
Joshua Russell ◽  
MaryLou Bodziak ◽  
Stephen Koury ◽  
Patricia Masso-Welch

Author(s):  
Tariq Aziz ◽  
Abid Sarwar ◽  
Muhammad Fahim ◽  
Sam Al Dalali ◽  
Zia Ud Din ◽  
...  

Lactobacillus plantarum YW11 capability to convert linoleic acid into conjugated linoleic acid and other metabolites was studied in a dose-dependent manner by supplementing LA at different concentrations. L. plantarum YW11 displayed a uniform distinctive growth curve of CLA and other metabolites at concentrations of LA ranging from 1% (w/v) to 10% (w/v), with slightly increased growth at higher LA concentrations. The biotransformation capability of L. plantarum YW11 evaluated by GC-MS revealed a total of one CLA isomer, i.e. 9-cis,11-trans-octadecadienoic acid, also known as the rumenic acid (RA), one linoleic acid isomer (linoelaidic acid), and LA metabolites: (E)-9-octadecenoic acid ethyl ester, trans, trans-9,12-octadecadienoic acid, propyl ester and stearic acid. All the metabolites of linoleic acid were produced from 1 to 10% LA supplemented MRS media, while surprisingly the only conjugated linoleic acid compound was produced at 10% LA. To assess the presence of putative enzymes, responsible for conversion of LA into CLA, in silico characterization was carried out. The in silico characterization revealed presence of four enzymes (10-linoleic acid hydratase, linoleate isomerase, acetoacetate decarboxylase and dehydrogenase) that may be involved in the production of CLA (rumenic acid) and LA isomers. The biotransformation ability of L. plantarum YW11 to convert LA into RA has great prospects for biotechnological and industrial implications that could be exploited in the future scale-up experiments.


2004 ◽  
Vol 70 (8) ◽  
pp. 4635-4641 ◽  
Author(s):  
E. Rosberg-Cody ◽  
R. P. Ross ◽  
S. Hussey ◽  
C. A. Ryan ◽  
B. P. Murphy ◽  
...  

ABSTRACT This study was designed to isolate different strains of the genus Bifidobacterium from the fecal material of neonates and to assess their ability to produce the cis-9, trans-11 conjugated linoleic acid (CLA) isomer from free linoleic acid. Fecal material was collected from 24 neonates aged between 3 days and 2 months in a neonatal unit (Erinville Hospital, Cork, Ireland). A total of 46 isolates from six neonates were confirmed to be Bifidobacterium species based on a combination of the fructose-6-phosphate phosphoketolase assay, RAPD [random(ly) amplified polymorphic DNA] PCR, pulsed-field gel electrophoresis (PFGE), and partial 16S ribosomal DNA sequencing. Interestingly, only 1 of the 11 neonates that had received antibiotic treatment produced bifidobacteria. PFGE after genomic digestion with the restriction enzyme XbaI demonstrated that the bifidobacteria population displayed considerable genomic diversity among the neonates, with each containing between one and five dominant strains, whereas 11 different macro restriction patterns were obtained. In only one case did a single strain appear in two neonates. All genetically distinct strains were then screened for CLA production after 72 h of incubation with 0.5 mg of free linoleic acid ml−1 by using gas-liquid chromatography. The most efficient producers belonged to the species Bifidobacterium breve, of which two different strains converted 29 and 27% of the free linoleic acid to the cis-9, trans-11 isomer per microgram of dry cells, respectively. In addition, a strain of Bifidobacterium bifidum showed a conversion rate of 18%/μg dry cells. The ability of some Bifidobacterium strains to produce CLA could be another human health-promoting property linked to members of the genus, given that this metabolite has demonstrated anticarcinogenic activity in vitro and in vivo.


2013 ◽  
Vol 12 (6) ◽  
pp. 516-520 ◽  
Author(s):  
Julakorn Panatuk ◽  
Suthipong Uriyapongs ◽  
Chainarong Nawanukraw ◽  
Chirasak Phoemchala ◽  
Pitukpol Pornanake

2012 ◽  
Vol 60 (45) ◽  
pp. 11323-11330 ◽  
Author(s):  
Maria I. Moran-Valero ◽  
Diana Martin ◽  
Guzman Torrelo ◽  
Guillermo Reglero ◽  
Carlos F. Torres

2014 ◽  
Vol 97 (10) ◽  
pp. 6164-6176 ◽  
Author(s):  
V.A. Absalón-Medina ◽  
S.J. Bedford-Guaus ◽  
R.O. Gilbert ◽  
L.C. Siqueira ◽  
G. Esposito ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document